Biological Therapy in Previously Treated Patients With Non-small Cell Lung Cancer
Phase 2
- Conditions
- First Posted Date
- 2004-08-02
- Last Posted Date
- 2013-11-06
- Lead Sponsor
- Cancer Biotherapy Research Group
- Target Recruit Count
- 30
- Registration Number
- NCT00003090
- Locations
- ๐บ๐ธ
Bergan Mercy Medical Center, Omaha, Nebraska, United States
๐บ๐ธSt. Joseph Regional Cancer Center, Bryan, Texas, United States
๐บ๐ธBloomington Hospital, Bloomington, Indiana, United States
Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer That Has Been Removed With Surgery
Phase 2
- Conditions
- First Posted Date
- 2004-07-16
- Last Posted Date
- 2013-11-06
- Lead Sponsor
- Cancer Biotherapy Research Group
- Target Recruit Count
- 20
- Registration Number
- NCT00003604
- Locations
- ๐บ๐ธ
Cancer Care Center for Southern Indiana, Bloomington, Indiana, United States
๐บ๐ธBergan Mercy Medical Center, Omaha, Nebraska, United States
๐บ๐ธBaptist Regional Cancer Center - Knoxville, Knoxville, Tennessee, United States
Combination Chemotherapy and Biological Therapy In Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed Surgically
Phase 2
- Conditions
- First Posted Date
- 2004-07-16
- Last Posted Date
- 2013-11-06
- Lead Sponsor
- Cancer Biotherapy Research Group
- Target Recruit Count
- 30
- Registration Number
- NCT00003664
- Locations
- ๐บ๐ธ
Bloomington Hospital, Bloomington, Indiana, United States
๐บ๐ธBergan Mercy Medical Center, Omaha, Nebraska, United States
ยฉ Copyright 2024. All Rights Reserved by MedPath